Investor Relations


SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and ... More »

pdf Corporate Presentation

Recent Releases

May 9, 2012
SciClone Reports Financial Results for the First Quarter 2012

May 2, 2012
SciClone Pharmaceuticals to Report Financial Results for the First Quarter 2012 on May 9th

View all releases »

Events & Presentations

Jun 7, 2012 at 10:00 AM PT
2012 Annual Meeting of Stockholders

May 9, 2012 at 4:30 PM ET
Q1 2012 SciClone Pharmaceuticals, Inc. Earnings

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 5.77
Change: - 0.10
Day High: 5.90
Day Low: 5.50
Volume: 376,800
Delayed at least 20 minutes.
Provided by eSignal.